FDA Enforcement Class II Terminated

VITROS Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection of immunoglobulin G antibody to hepatitis C virus (anti-HCV) in human serum and plasma. REF 680 2454, IVD -- Ortho-Clinical Diagnostics High Wycombe UK. Note that one sales unit has 5 Reagent Packs contained within it. Each Reagent Pack can test for 100 samples (patient, Quality Control, etc.).

Recall: Z-2671-2014 · Reported October 1, 2014

Enforcement

Recall Number
Z-2671-2014
Event ID
68974
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
ORTHO-CLINICAL DIAGNOSTICS
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
October 1, 2014
Initiation Date
August 6, 2014
Classification Date
September 19, 2014
Termination Date
April 14, 2017
Address
FELINDRE MEADOWS, N/A, Bridgend, N/A, N/A, United Kingdom

Description

VITROS Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection of immunoglobulin G antibody to hepatitis C virus (anti-HCV) in human serum and plasma. REF 680 2454, IVD -- Ortho-Clinical Diagnostics High Wycombe UK. Note that one sales unit has 5 Reagent Packs contained within it. Each Reagent Pack can test for 100 samples (patient, Quality Control, etc.).

Reason

VITROS Immunodiagnostic Products Anti-HCV kit lot 9090 has been observed producing sporadic lower than expected VITROS Anti-HCV test results due to an approximate signal loss of up to 66.2% which can result in unexpected negative test results being obtained for reactive sample fluids (quality control and patient samples).

Code Info

Lot 9090 (exp. December 15, 2014)

Distribution

NY, NJ, CT, MA, PA, VA, MD, FL and GA

Quantity

463 sales units